- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01684592
Phone-Based Postpartum Continuing Care for Smoking Cessation (PPCC)
Phone-Based Postpartum Continuing Care: Smoking Cessation Beginning in Pregnancy
연구 개요
상세 설명
The large majority of women who quit smoking during pregnancy relapse in the first six months postpartum, highlighting a need for effective postpartum continuing care that supports women through the challenging postpartum period when stress is high and motivation to stay quit may decline. Existing relapse prevention interventions (typically delivered during pregnancy) have been found to be of little benefit during the postpartum period, suggesting the need for a more formal continuing care approach. Phone-based protocols for smoking cessation have been widely disseminated and effective because they address the need for flexible access, but are passive and not typically utilized by women in the postpartum period.
The proposed pilot study will develop and test a Phone-based Postpartum Continuing Care (PPCC) model that draws from existing evidence-based protocols--the 5 A's and Recovery Management Checkups (RMC)-- shown to be effective with other populations. The experimental PPCC will reinforce the importance of abstinence, relapse prevention, and reduced smoking through proactive re-intervention (i.e., RMC) with the 5 A's at times when postpartum women are more likely to relapse, and provide education and monitoring of the infant's direct and indirect exposure to nicotine through breastfeeding and secondhand smoke. We will evaluate PPCC's effectiveness relative to a passive referral to a 24/7 hotline, which is current standard care.
Approximately one hundred thirty women in their first or second trimester of pregnancy who were nicotine-dependent in the past year, currently smoke, or quit within the past 90 days will be recruited at their first prenatal appointment at the Maryland Women's Center (MWC) in Baltimore, Maryland. All women will receive the clinic's standard of care for smoking cessation--the 5 A's --during pregnancy from their physician. Half will be randomly assigned to an experimental group getting PPCC for 6 months postpartum and half to a control group receiving only a referral to a passive 24/7 state quit line postpartum. It is expected that in the 6 months following childbirth women in the experimental PPCC (relative to those in the control group) will: a) smoke fewer cigarettes, b) smoke fewer days, c) go longer before postpartum relapse, d) have less time between relapse and talking to a health professional about smoking, e) have less time between relapse and resumption of abstinence , f) smoke fewer times while breastfeeding, g) smoke fewer times while in the same room as the infant, and h) reduce their infant's cotinine levels.
The aims of this pilot project are to develop PPCC from existing evidence-based approaches, demonstrate the feasibility of implementing the PPCC intervention with at least 80% compliance and at least 80% follow-up at each wave, and evaluate the effect size associated with receiving standard care vs. standard care + PPCC in order to understand the promise of and appropriate power required for a larger clinical trial.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Illinois
-
Bloomington, Illinois, 미국, 61701
- Chestnut Global Partners
-
-
Maryland
-
Baltimore, Maryland, 미국, 21201
- Maryland Women's Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- first or second trimester of pregnancy
- age 18 or older
- self-reported tobacco use in the past 90 days or nicotine-dependence in the past year
Exclusion Criteria:
- intend to terminate their pregnancy
- intend to move out of the city within the next 12 months
- are unable to provide informed consent and participate in English
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
활성 비교기: Standard care
Standard care for smokers during pregnancy and referral to 24/7 quitline postpartum (passive)
|
All women will receive the standard of care approach (5 A's and referral to a 24/7 quit line postpartum) from MWC during pregnancy.
The 5 A's brief intervention was modified by American College of Obstetricians and Gynecologists (ACOG) for use with pregnant women and is recommended to help pregnant women quit smoking.
It includes the following steps: Ask about tobacco use, Advise to quit, Assess willingness to make a quit attempt, Assist in quit attempt, and Arrange follow-up.
|
실험적: Standard care plus PPCC
Standard care for smoking during pregnancy and proactive phone-based postpartum continuing care (PPCC) for 6 months postpartum
|
All women will receive the standard of care approach (5 A's and referral to a 24/7 quit line postpartum) from MWC during pregnancy.
The 5 A's brief intervention was modified by American College of Obstetricians and Gynecologists (ACOG) for use with pregnant women and is recommended to help pregnant women quit smoking.
It includes the following steps: Ask about tobacco use, Advise to quit, Assess willingness to make a quit attempt, Assist in quit attempt, and Arrange follow-up.
PPCC Counselors will make initial contact with participants in the experimental group at 36 weeks gestation (i.e., one week prior to full-term), will call again within one week after the baby's birth, and eight additional times over the course of the first six months postpartum.
The PPCC protocol will be developed based on the 5 A's (standard of care during pregnancy) and the Recovery Management Checkup model where relapse is expected and efforts are made to take a more proactive approach to identify women who are having cravings or have relapsed and re-intervene with them as soon as possible to assist them in regaining smoking abstinence.
Women in the experimental group will also have the option of calling the PPCC line 24 hours a day, 7 days a week.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Number of Tobacco Products Per Day
기간: 6 months postpartum
|
Self-reported number of tobacco products smoked per day
|
6 months postpartum
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Number of Tobacco Products Per Day
기간: 3 months postpartum
|
Self-reported number of tobacco products smoked per day
|
3 months postpartum
|
Past 90-day Tobacco Use
기간: 3 months postpartum
|
Self-reported number of days smoked in past 90 days
|
3 months postpartum
|
Past 90-day Tobacco Use
기간: 6 months postpartum
|
Self-reported number of days smoked tobacco in past 90 days.
|
6 months postpartum
|
Times Mother Smoked While Breastfeeding
기간: Baby's birth to 6 months postpartum
|
Based on the days of smoking while breastfeeding (or within 30 minutes of breastfeeding) times the frequency of use on day.
|
Baby's birth to 6 months postpartum
|
Times Mother Smoked in the Room With Infant
기간: Baby's birth to 6 months postpartum
|
Based on the number of days of smoking in the same room with infant in the past 90.
|
Baby's birth to 6 months postpartum
|
NicCheck Test Results for Cotinine Level From Infant Urine
기간: 6 months postpartum
|
Infant urine was collected at 6 months postpartum using the "cotton roll" method of urine collection.
Cotinine was measured with NicCheck I Test Strips that determine the urinary concentration of nicotine and its metabolites based on a colorimetric reaction.
The test strip is dipped into participant's urine and changes color (varying shades of pink) in the presence of cotinine.
Cotinine level is determined by matching the test strip with a color chart provided by the manufacturer.
The intensity of color on the strip at the end of 15 minutes may be compared to those on the color chart, to differentiate between "low" (score 1-6) versus "high" (score 7-14) nicotine consumption.
Absence of a color is considered a negative result (score 0).
Based on comparison with gas chromatography urine cotinine values, individuals with cotinine values of 200 ng/mL and above are classified as smokers.
|
6 months postpartum
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Victoria H Coleman-Cowger, PhD, Battelle Memorial Institute
- 연구 책임자: Katrina Mark, MD, University of Maryland School of Medicine
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Standard care에 대한 임상 시험
-
Nebraska Methodist Health SystemAcera Surgical, Inc.종료됨
-
Pfizer모집하지 않고 적극적으로성인 혈우병 B 피험자(FIX:C≤2%) 또는 성인 혈우병 A 피험자(FVIII:C≤1%)에서 현재 FVIII 예방 대체 요법의 전향적 효능 및 안전성 데이터를 평가하기 위한 연구혈우병 A | 혈우병 B미국, 캐나다, 스페인, 호주, 대한민국, 대만, 브라질, 이탈리아, 일본, 칠면조, 독일, 영국, 사우디 아라비아, 프랑스, 스웨덴, 벨기에, 그리스, 이스라엘
-
Compedica IncProfessional Education and Research Institute모병
-
Kuros Biosurgery AG완전한당뇨성 족부궤양체코 공화국, 독일, 헝가리, 루마니아, 러시아 연방, 세르비아
-
ULURU Inc.Navy Advanced Medical Development (NAMD) Command모집하지 않고 적극적으로
-
Occlutech International AB모병뇌졸중 | 특허 구멍 타원형미국, 덴마크, 캐나다, 네덜란드, 독일, 영국, 핀란드